Day: November 1, 2024

KUALA LUMPUR, Malaysia, Nov. 01, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global” or the “Company”), a diversified holding company with expertise in consulting, fintech, AI, robotics and cybersecurity, is pleased to announce the approved 1-for-49 stock split of the Company’s common stock with no par value, effective at 12:01 a.m. Eastern Time on 5 November, 2024 (the “Reverse Stock Split”). VCI Global’s common stock will continue to be traded on the Nasdaq Capital Market on a split-adjusted basis beginning on 5 November, 2024, under the Company’s existing trading symbol “VCIG” with the new CUSIP number G98218 202. The Reverse Stock Split is primarily intended to increase the market price per share of the Company’s common stock to regain compliance with the minimum bid price required for continued...

NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) — Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC (“Kyber”), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition strengthens Forian’s position in the healthcare information marketplace through the addition of advanced analytics and software capabilities and expands the industries Forian serves to include financial services. Kyber has established a leading reputation for its innovative approach to real world healthcare data, leveraging cutting-edge analytics to help financial organizations make informed healthcare investment...

COMPANY ANNOUNCEMENT no. 77 – 1 November 2024 EBIT 2024 outlook range lowered to DKK 1.5-1.7bn from DKK 1.7-2.1bn Adjusted free cash flow 2024 outlook is changed to around DKK 1.2bn fromaround DKK 1.5bnDFDS’ EBIT outlook range for 2024 is revised following results below expectations driven by mainly a more widespread slowdown in Europe than previously expected as well as intensified competition in northern European land transport markets and the Mediterranean freight ferry market. The current market conditions are expected to continue for the rest of the year whilst a rebound in activity was previously expected for the rest of the year. The termination of the share purchase agreement to acquire the international transport network of Ekol Logistics, announced earlier today, may moreover in Q4 2024 entail some financial...

COMPANY ANNOUNCEMENT no. 76 – 1 November 2024 In April 2024, DFDS entered into a share purchase agreement to acquire the international transport network of Ekol Logistics. As noted in the company announcement no. 24 of 9 April 2024, completion of the transaction was conditional upon regulatory approvals and certain contractual conditions. As certain contractual conditions have not been satisfied by the agreed deadline, DFDS has terminated the share purchase agreement and the transaction will consequently not take place.Contact Torben Carlsen, CEO +45 33 42 32 01 Karen Boesen, CFO +45 20 58 58 40 Søren Brøndholt Nielsen, IR +45 33 42 33 59 Dennis Kjærsgaard, Media +45 42 30 38 47About DFDS We operate a transport network in and around Europe with an annual revenue of DKK 28bn and 14,000 full-time employees. We move goods...

Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the commercial rollout of its CompuFlo® Epidural System at Hudson Specialty Care, led by renowned physician Dr. Elbaz. This latest agreement is a direct result of the Company’s recent partnership with Axial Biologics, underscoring the success of this collaboration as Milestone’s sales pipeline expands, with additional pilot programs underway in New Jersey, Texas, and Florida. This agreement also follows CompuFlo’s recent Medicare Part B Physician payment rate with...

ANCHORAGE, Alaska, Nov. 01, 2024 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today announced the acquisition of Sallyport Commercial Finance, LLC (“Sallyport” or “SCF”) in an all cash transaction that closed on October 31, 2024 and is valued at approximately $53.9 million. Sallyport Commercial Finance, LLC is a leading provider of factoring, asset based lending and alternative working capital solutions to small and medium sized enterprises in the United States and Canada. The transaction is expected to provide earnings accretion of approximately 15% to Northrim’s 2025 operating results. “Having worked with Nick and the Sallyport team for several years, we have been impressed by the quality of the business they have built,” said Mike Huston, President and CEO of Northrim. “We view this as...

SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of certain liabilities. Merit funded the acquisition payment through a combination of cash on hand and borrowings under its long-term credit facility. “We are pleased to announce the completion of this important acquisition,” said Fred P. Lampropoulos, Merit’s Chairman and Chief Executive Officer. “We are excited to welcome the talented team from Cook Medical’s lead management business. We believe this acquisition will strengthen our fast-growing, high-margin electrophysiology and CRM business,...

$15 million upfront with up to an additional $34 million of aggregate gross proceeds upon the exercise in full for cash of long-term and milestone-linked warrants TEL AVIV, ISRAEL, Nov. 01, 2024 (GLOBE NEWSWIRE) — Arbe Robotics Ltd. (NASDAQ, TASE: ARBE) (“Arbe” or the “Company”), a global leader in Perception Radar Solutions, today announced the pricing of a public offering of an aggregate of 8,250,000 ordinary shares (or pre-funded warrants in lieu thereof) accompanied by Tranche A Warrants to purchase up to 8,250,000 ordinary shares and Tranche B Warrants to purchase up to 8,250,000 ordinary shares, at a combined public offering price of $1.82 per share (or per pre-funded warrant in lieu thereof) and accompanying Tranche A Warrant and Tranche B Warrant. The Tranche A Warrants will have an exercise price of $2.35 per share, will...